89 related articles for article (PubMed ID: 8760043)
1. Angiotensin-converting enzyme inhibitors regulate the Na(+)-K+ pump via effects on angiotensin metabolism.
Hool LC; Gray DF; Robinson BG; Rasmussen HH
Am J Physiol; 1996 Jul; 271(1 Pt 1):C172-80. PubMed ID: 8760043
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin regulates the selectivity of the Na+-K+ pump for intracellular Na+.
Buhagiar KA; Hansen PS; Gray DF; Mihailidou AS; Rasmussen HH
Am J Physiol; 1999 Sep; 277(3):C461-8. PubMed ID: 10484333
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cepsilon contributes to regulation of the sarcolemmal Na(+)-K(+) pump.
Buhagiar KA; Hansen PS; Bewick NL; Rasmussen HH
Am J Physiol Cell Physiol; 2001 Sep; 281(3):C1059-63. PubMed ID: 11502584
[TBL] [Abstract][Full Text] [Related]
4. Dietary cholesterol alters Na+/K+ selectivity at intracellular Na+/K+ pump sites in cardiac myocytes.
Buhagiar KA; Hansen PS; Kong BY; Clarke RJ; Fernandes C; Rasmussen HH
Am J Physiol Cell Physiol; 2004 Feb; 286(2):C398-405. PubMed ID: 14522815
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition, intracellular Na+, and Na(+)-K+ pumping in cardiac myocytes.
Hool LC; Whalley DW; Doohan MM; Rasmussen HH
Am J Physiol; 1995 Feb; 268(2 Pt 1):C366-75. PubMed ID: 7864075
[TBL] [Abstract][Full Text] [Related]
6. Oxidative inhibition of the vascular Na+-K+ pump via NADPH oxidase-dependent β1-subunit glutathionylation: implications for angiotensin II-induced vascular dysfunction.
Liu CC; Karimi Galougahi K; Weisbrod RM; Hansen T; Ravaie R; Nunez A; Liu YB; Fry N; Garcia A; Hamilton EJ; Sweadner KJ; Cohen RA; Figtree GA
Free Radic Biol Med; 2013 Dec; 65():563-572. PubMed ID: 23816524
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule.
Cheng HF; Becker BN; Burns KD; Harris RC
J Clin Invest; 1995 May; 95(5):2012-9. PubMed ID: 7738168
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase-dependent oxidative regulation of the cardiac Na+-K+ pump: evidence from in vivo and in vitro modulation of cell signalling.
Galougahi KK; Liu CC; Garcia A; Fry NA; Hamilton EJ; Rasmussen HH; Figtree GA
J Physiol; 2013 Jun; 591(12):2999-3015. PubMed ID: 23587884
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II modulates the activity of Na+,K+-ATPase in cultured rat astrocytes via the AT1 receptor and protein kinase C-delta activation.
Muscella A; Aloisi F; Marsigliante S; Levi G
J Neurochem; 2000 Mar; 74(3):1325-31. PubMed ID: 10693967
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II AT1 receptor/signaling mechanisms in the biphasic effect of the peptide on proximal tubular Na+,K+-ATPase.
Bharatula M; Hussain T; Lokhandwala MF
Clin Exp Hypertens; 1998 May; 20(4):465-80. PubMed ID: 9607407
[TBL] [Abstract][Full Text] [Related]
12. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Ottlecz A; Bensaoula T
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin I modulates Ca-transport systems in the rat heart through angiotensin II.
Krizanova O; Orlicky J; Masanova C; Juhaszova M; Hudecova S
J Mol Cell Cardiol; 1997 Jun; 29(6):1739-46. PubMed ID: 9220359
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II inhibits the Na+-K+ pump via PKC-dependent activation of NADPH oxidase.
White CN; Figtree GA; Liu CC; Garcia A; Hamilton EJ; Chia KK; Rasmussen HH
Am J Physiol Cell Physiol; 2009 Apr; 296(4):C693-700. PubMed ID: 19193863
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
[TBL] [Abstract][Full Text] [Related]
17. Atypical PKC-zeta and PKC-iota mediate opposing effects on MCF-7 Na+/K+ATPase activity.
Muscella A; Storelli C; Marsigliante S
J Cell Physiol; 2005 Nov; 205(2):278-85. PubMed ID: 15887250
[TBL] [Abstract][Full Text] [Related]
18. Angiotensins II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors.
Pawlikowski M; Gruszka A; Mucha S; Melen-Mucha G
Endocr Regul; 2001 Sep; 35(3):139-42. PubMed ID: 11674842
[TBL] [Abstract][Full Text] [Related]
19. Reversible oxidative modification: a key mechanism of Na+-K+ pump regulation.
Figtree GA; Liu CC; Bibert S; Hamilton EJ; Garcia A; White CN; Chia KK; Cornelius F; Geering K; Rasmussen HH
Circ Res; 2009 Jul; 105(2):185-93. PubMed ID: 19542013
[TBL] [Abstract][Full Text] [Related]
20. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
Babiker F; Al-Jarallah A; Joseph S
PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
